Thomas Shrader
Stock Analyst at BTIG
(3.11)
# 1,204
Out of 5,113 analysts
72
Total ratings
43.94%
Success rate
3.28%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Reiterates: Buy | $19 | $9.63 | +97.30% | 1 | Jan 20, 2026 | |
| IRD Opus Genetics | Initiates: Buy | $7 | $2.81 | +149.11% | 1 | Jan 20, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $25 | $2.12 | +1,079.25% | 2 | Jan 15, 2026 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $72 → $147 | $86.15 | +70.63% | 3 | Jan 7, 2026 | |
| IVVD Invivyd | Reiterates: Buy | $10 | $2.05 | +387.80% | 2 | Dec 23, 2025 | |
| DNLI Denali Therapeutics | Reiterates: Buy | $32 | $20.61 | +55.26% | 3 | Dec 5, 2025 | |
| BHVN Biohaven | Reiterates: Buy | $16 | $12.74 | +25.59% | 5 | Nov 18, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $27 | $16.41 | +64.53% | 1 | Nov 17, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $15 → $16 | $4.68 | +241.88% | 3 | Nov 13, 2025 | |
| PCVX Vaxcyte | Reiterates: Buy | $85 | $53.40 | +59.18% | 6 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $5.23 | +72.08% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $39 | $29.25 | +33.33% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.48 | +129.89% | 3 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $23 | $7.36 | +212.50% | 2 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.93 | - | 4 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.95 | +361.54% | 4 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $14 | $6.90 | +102.90% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $63 | $43.83 | +43.74% | 3 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.67 | - | 3 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.74 | +129.89% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $8.97 | +2,129.65% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $60 | $4.04 | +1,385.15% | 1 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $6.66 | +5.11% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $13 | $0.35 | +3,578.55% | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $2.08 | +957.69% | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $1.29 | +3,853.49% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.50 | +190.91% | 1 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.00 | - | 1 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.37 | +118.98% | 3 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $397 → $346 | $173.12 | +99.87% | 3 | Feb 21, 2019 |
Novavax
Jan 20, 2026
Reiterates: Buy
Price Target: $19
Current: $9.63
Upside: +97.30%
Opus Genetics
Jan 20, 2026
Initiates: Buy
Price Target: $7
Current: $2.81
Upside: +149.11%
NRx Pharmaceuticals
Jan 15, 2026
Reiterates: Buy
Price Target: $25
Current: $2.12
Upside: +1,079.25%
Bright Minds Biosciences
Jan 7, 2026
Maintains: Buy
Price Target: $72 → $147
Current: $86.15
Upside: +70.63%
Invivyd
Dec 23, 2025
Reiterates: Buy
Price Target: $10
Current: $2.05
Upside: +387.80%
Denali Therapeutics
Dec 5, 2025
Reiterates: Buy
Price Target: $32
Current: $20.61
Upside: +55.26%
Biohaven
Nov 18, 2025
Reiterates: Buy
Price Target: $16
Current: $12.74
Upside: +25.59%
Alto Neuroscience
Nov 17, 2025
Initiates: Buy
Price Target: $27
Current: $16.41
Upside: +64.53%
Coya Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $4.68
Upside: +241.88%
Vaxcyte
Nov 10, 2025
Reiterates: Buy
Price Target: $85
Current: $53.40
Upside: +59.18%
Nov 10, 2025
Reiterates: Buy
Price Target: $9
Current: $5.23
Upside: +72.08%
Nov 5, 2025
Reiterates: Buy
Price Target: $39
Current: $29.25
Upside: +33.33%
Nov 4, 2025
Reiterates: Buy
Price Target: $8
Current: $3.48
Upside: +129.89%
Oct 22, 2025
Maintains: Buy
Price Target: $48 → $23
Current: $7.36
Upside: +212.50%
Oct 22, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.93
Upside: -
Oct 15, 2025
Reiterates: Buy
Price Target: $9
Current: $1.95
Upside: +361.54%
Oct 13, 2025
Maintains: Buy
Price Target: $7 → $14
Current: $6.90
Upside: +102.90%
Sep 29, 2025
Reiterates: Buy
Price Target: $63
Current: $43.83
Upside: +43.74%
Jul 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.67
Upside: -
Mar 24, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.74
Upside: +129.89%
Oct 3, 2023
Initiates: Buy
Price Target: $200
Current: $8.97
Upside: +2,129.65%
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $4.04
Upside: +1,385.15%
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $6.66
Upside: +5.11%
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $0.35
Upside: +3,578.55%
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $2.08
Upside: +957.69%
Apr 20, 2021
Initiates: Buy
Price Target: $51
Current: $1.29
Upside: +3,853.49%
Mar 8, 2021
Initiates: Buy
Price Target: $16
Current: $5.50
Upside: +190.91%
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $4.00
Upside: -
Apr 3, 2020
Maintains: Buy
Price Target: $4 → $3
Current: $1.37
Upside: +118.98%
Feb 21, 2019
Downgrades: Hold
Price Target: $397 → $346
Current: $173.12
Upside: +99.87%